Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2026 (year ended September 2026) was $337.4 billion, up 5.00% from fiscal 2025.
- Revenue
- +5.52%
- EPS
- +258.4%
- Free cash flow
- −7.81%
- Total debt
- +47.1%
Quarter to September 2026, against a year earlier
Follow COR
Alert me
Cencora, Inc. (COR) Operating cash flow
Cencora, Inc.'s operating cash flow for fiscal 2026 was $4.8B, up 23.6% from $3.9B in fiscal 2025. Over the past ten years it has ranged from $1.4B (fiscal 2018) to $4.8B (fiscal 2026) — the current reading is the highest in ten years. Cencora, Inc. ranks 3rd of 12 Medical Distribution companies by operating cash flow.
Operating cash flow, annual
Embed this chart
Annual newest first
| Period | Operating cash flow | Change |
|---|---|---|
| FY2026 | $4.8B | 23.61% |
| FY2025 | $3.9B | 11.20% |
| FY2024 | $3.5B | (10.91%) |
| FY2023 | $3.9B | 44.70% |
| FY2022 | $2.7B | 1.37% |
| FY2021 | $2.7B | 20.82% |
| FY2020 | $2.2B | (5.84%) |
| FY2019 | $2.3B | 66.08% |
| FY2018 | $1.4B | (6.17%) |
| FY2017 | $1.5B | (52.68%) |
Quarterly newest first
| Period | Operating cash flow | Change |
|---|---|---|
| Sep 2026 | $3.1B | 16.90% |
| Jun 2026 | $2.7B | 98.27% |
| Mar 2026 | $1.3B | — |
| Dec 2025 | −$2.3B | — |
| 43 more quarters | Free account |
Against its own ten years
Operating cash flow against peers
| Company | Operating cash flow |
|---|---|
| MCK McKesson Corporation compare | $7.5B |
| CAH Cardinal Health, Inc. compare | $5.2B |
| COR Cencora, Inc. | $4.8B |
| HSIC Henry Schein, Inc. compare | $687.0M |
| AHG Akso Health Group Sponsored ADR compare | $17.0M |
| COSM Cosmos Health Inc. compare | −$9.8M |
| YI 111, Inc. Sponsored ADR compare | −$11.8M |
| FOCL FocalTherics compare | −$13.0M |
| ACH Accendra Health, Inc. compare | −$180.4M |
What Operating cash flow is
Operating Cash Flow shows how much cash a company’s day-to-day business actually brings in, after paying suppliers, staff and taxes.
Reported line item
More on COR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement